GO
Loading...

Enter multiple symbols separated by commas

Switzerland

More

  • Novartis Plans Restructuring, Job Cuts: WSJE Tuesday, 11 Dec 2007 | 3:50 AM ET

    Novartis plans a restructuring that will result in job cuts and the removal of several layers of management, according to an interview with CEO Daniel Vasella in the Wall Street Journal Europe.

  • UBS revealed a $10 billion writedown and an emergency injection of funds from Singapore and the Middle East, making it the biggest victim of the U.S. subprime crisis to date among major European banks.

  • Sometimes weekend newspaper pickups go nowhere and sometimes you hit pay dirt. This morning, putting together "Squawk Box Europe", the team debated the merits of a story carried by the Swiss weekly the Sonntagszeitung. It said UBS management held an unscheduled board meeting at the weekend and could announce more sizeable writedowns.

  • Nestle to Sell Jamba Juice in Grocery Stores Tuesday, 4 Dec 2007 | 10:49 AM ET

    Jamba said it is partnering with Nestle USA to sell bottled smoothies and juice drinks at U.S. grocery stores, sending the company's shares up 28 percent.

  • Swiss Life Shrugs off Credit Crisis, Boosts Targets Tuesday, 4 Dec 2007 | 4:13 AM ET

    Insurer Swiss Life raised its targets on Tuesday, aiming to boost earnings per share by at least 12 percent annually, and said the credit crisis will not hit its results, lifting its shares.

  • Swiss Life to Buy German AWD in $1.7 Billion Deal Monday, 3 Dec 2007 | 4:39 AM ET

    Swiss Life advanced a sweeping restructuring on Monday, unveiling plans to buy German investment adviser AWD in an agreed deal valuing AWD at 1.16 billion euros ($1.71 billion).

  • UBS Shares Wobble on Subprime Concerns Tuesday, 20 Nov 2007 | 7:28 AM ET

    Shares in Swiss-based bank UBS tumbled temporarily on Tuesday on renewed fears the group may have to make more hefty writedowns for exposure to assets hit by the subprime crisis.

  • Roche Says Avastin Study Misses Endpoint Tuesday, 13 Nov 2007 | 5:54 AM ET

    Roche on Tuesday said a late-stage study of its cancer drug Avastin in combination with gemcitabine chemotherapy and Tarceva for pancreatic cancer did not meet the primary endpoint for survival.

  • Swiss Re Profit Falls Less than Expected Tuesday, 6 Nov 2007 | 7:00 AM ET

    Net profit at Swiss Re dropped by less than expected in the third quarter, as the world's largest reinsurer benefited from low claims and said damage from a global credit crisis was limited.

  • Novartis Diabetes Drug Faces Further Delays Tuesday, 6 Nov 2007 | 3:44 AM ET
    Novartis

    Novartis has found safety problems in higher doses of its key Galvus diabetes drug and will revise prescribing recommendations before launching in Europe.

  • Nestle Sees 2007 Sales Well Above $86.58 Billion Monday, 5 Nov 2007 | 5:27 AM ET

    Nestle expects full-year sales to be well above 100 billion Swiss francs ($86.58 billion) this year, the head of the world's largest food group was quoted as saying over the weekend.

  • Credit Suisse Profit Tumbles on Writedowns Thursday, 1 Nov 2007 | 11:31 AM ET

    Credit Suisse reported a 31 percent fall in group net profits to 1.302 billion Swiss francs ($1.12 billion),  with profit at its investment banking unit all but wiped out by mortgage-linked writedowns.

  • UBS Swings to Loss, Facing Subprime Problems Tuesday, 30 Oct 2007 | 12:16 PM ET
    UBS

    UBS reported a bigger-than-expected third-quarter pretax loss of 726 million Swiss francs ($624.8 million) on Tuesday, but said it expected to turn in a group profit in the last quarter.

  • Nestle CEO: L'Oreal Stake Sale is "One Option" Thursday, 18 Oct 2007 | 5:56 AM ET

    Nestle said on Thursday a sale of its stake in French cosmetics group L'Oreal was one option to be considered after a lock-up agreement with the controlling family expires in 2009.

  • Novartis Cuts US Jobs as Third-Quarter Profit Falls 12% Thursday, 18 Oct 2007 | 3:36 AM ET

    Swiss drugmaker Novartis's third-quarter net profit missed forecasts, dropping by 12 percent to $1.57 billion, weighed down by the launch of rival generic versions of its drugs and a one-off charge.

  • Roche Sales Fall Short on Tamiflu Weakness Tuesday, 16 Oct 2007 | 5:28 AM ET

    Shares in Roche Holding slump on Tuesday after Swiss pharmaceutical company reported sales that came in below analysts' forecasts.

  • Oil and Gas Demand Helps Sulzer Orders Tuesday, 16 Oct 2007 | 3:30 AM ET

    Swiss engineering group Sulzer posted a 27.5 percent rise in nine-month orders on Tuesday and was upbeat about its outlook as the group benefits from demand in the oil and gas sector and growthin Asia.

  • The global credit crisis is far from over and may come in waves, a source close to the Basel Committee on Banking Supervision said on Friday.

  • Swiss Consumer Inflation Lower than Expected Tuesday, 2 Oct 2007 | 4:07 AM ET

    Swiss consumer price inflation picked up in September, driven by higher oil prices, but the price rise was smaller than expected.

  • UBS to Write Down $3.42 Billion Due to Credit Woes Monday, 1 Oct 2007 | 10:55 AM ET
    UBS headquarters in Zurich, Switzerland.

    UBS, the world's largest wealth manager, unveiled $3.4 billion in losses, swept out senior managers and slashed jobs in one of the biggest casualties yet from the worldwide credit crunch.